Russell Miller
Pfizer (United States)(US)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Computability, Logic, AI Algorithms, Mitochondrial Function and Pathology, Diabetes Treatment and Management
Most-Cited Works
- → Essential Regulation of Cell Bioenergetics by Constitutive InsP3 Receptor Ca2+ Transfer to Mitochondria(2010)1,002 cited
- → Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin(2010)872 cited
- → Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP(2013)825 cited
- → MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival(2012)649 cited
- → MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism(2012)485 cited
- → Erratum: Corrigenda: MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism(2015)420 cited
- → Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration(2012)329 cited
- → Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice(2017)260 cited
- → Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms(2014)179 cited
- → Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling(2011)173 cited